Itami

Diclofenac sodium, the active ingredient in Itami, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical formulation for cutaneous use. It is indicated for relief of mild to moderate musculoskeletal pain and for reduction of inflammation in conditions such as osteoarthritis, rheumatoid arthritis, sprains and strains. GNH USA supplies Itami as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac sodium works locally on inflamed tissues and is used for several musculoskeletal conditions. - Musculoskeletal pain: provides topical analgesia for mild to moderate pain. - Osteoarthritis: reduces joint inflammation and improves mobility. - Rheumatoid arthritis: alleviates localized joint swelling and discomfort. - Sprains and strains: diminishes swelling and speeds functional recovery.

Topical diclofenac may cause local and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: redness, itching or burning at the application site. - Dryness: localized dryness or peeling of the skin. - Pruritus: mild itching without rash. - Erythema: transient redness of the treated area.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or difficulty breathing. - Severe dermatitis: blistering or extensive rash. - Systemic NSAID effects: rare gastrointestinal upset or headache. - Photosensitivity: increased skin sensitivity to sunlight. - Stevens‑Johnson syndrome: extremely rare severe skin reaction.

When using a topical NSAID, certain safety measures should be observed. - Avoid application on broken or infected skin: may increase systemic absorption. - Do not use on large surface areas: limits systemic exposure. - Keep away from eyes and mucous membranes: can cause irritation. - Discontinue if severe skin reaction occurs: seek medical advice. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Topical diclofenac can interact with systemic medications that affect bleeding or renal function.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal and renal toxicity. - Lithium: potential increase in lithium levels. - Methotrexate: enhanced methotrexate toxicity. - Systemic corticosteroids: heightened risk of ulceration.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible renal function changes. - Diuretics: monitor renal parameters. - SSRIs or SNRIs: modest increase in bleeding tendency. - Beta‑blockers: watch for blood pressure alterations. - Alcohol: may exacerbate gastrointestinal irritation.